Rani Therapeutics Holdings, Inc. Insider Transactions
Rani Therapeutics Holdings, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
McKinley Kate
Chief Business Officer |
Buy | 17,960 @ $1.67 | $29,993 | 17,960 | 12/13/2024 | 12/16/2024 | |
Imran Talat
CEO |
Buy | 10,296 @ $1.94 | $19,974 | 494,751 | 12/09/2024 | 12/10/2024 | |
South Cone Investments Limited Partnership
10 percent owner |
Sell | 3,305,622 @ $2.55 | $8.44 M | 8,825,932 | 10/15/2024 | 10/17/2024 | |
South Cone Investments Limited Partnership
10 percent owner |
Sell | 523,738 @ $3.26 | $1.71 M | 8,302,194 | 10/15/2024 | 10/17/2024 | |
Imran Talat
CEO |
Buy | 10,000 @ $2.27 | $22,700 | 484,455 | 12/06/2023 | 12/07/2023 | |
Imran Talat
CEO |
Buy | 5,000 @ $2.57 | $12,850 | 474,455 | 12/04/2023 | 12/06/2023 | |
Imran Talat
CEO |
Buy | 20,000 @ $2.05 | $41,000 | 469,455 | 11/29/2023 | 12/01/2023 | |
Quiroga Cortes Isidoro Alfonso
10 percent owner |
Sell | 5,265,165 @ $2.01 | $10.58 M | 8,400 | 11/24/2023 | 12/08/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 5,265,165 @ $2.01 | $10.58 M | 12,131,554 | 11/24/2023 | 12/08/2023 | |
BUTEL JEAN LUC
Director |
Buy | 50,500 @ $2.03 | $102,495 | 50,500 | 11/17/2023 | 11/21/2023 | |
Nanavaty Maulik
Director |
Buy | 500 @ $1.98 | $990 | 500 | 11/16/2023 | 11/20/2023 | |
Imran Talat
CEO |
Buy | 2,500 @ $1.98 | $4,950 | 446,955 | 11/07/2023 | 11/09/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 2,645 @ $3.98 | $10,529 | 6,866,389 | 05/12/2023 | 05/15/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 2,610 @ $3.87 | $10,096 | 6,863,744 | 05/11/2023 | 05/15/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 4,420 @ $4.46 | $19,733 | 6,861,134 | 05/08/2023 | 05/10/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 2,040 @ $4.81 | $9,816 | 6,856,714 | 05/03/2023 | 05/05/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 2,173 @ $4.71 | $10,225 | 6,854,674 | 04/28/2023 | 05/02/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 4,423 @ $4.51 | $19,952 | 6,852,501 | 04/25/2023 | 04/26/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 4,280 @ $4.67 | $19,994 | 6,848,078 | 04/24/2023 | 04/26/2023 | |
South Cone Investments Limited Partnership
10 percent owner |
Buy | 4,100 @ $4.93 | $20,224 | 6,843,798 | 04/21/2023 | 04/24/2023 |
Rani Therapeutics Holdings, Inc. FAQ's
The list of insiders at Rani Therapeutics Holdings, Inc. includes South Cone Investments Limited Partnership, Imran Talat, McKinley Kate.
Insiders have sold a total of 3.83 M Rani Therapeutics Holdings, Inc. shares in the last 12 months for a total of 10.14 M sold.
The following insiders have sold Rani Therapeutics Holdings, Inc. shares in the last 12 months: South Cone Investments Limited Partnership ($10.14 M),
Insiders have purchased a total of 28,256 Rani Therapeutics Holdings, Inc. shares in the last 12 months for a total of 49,967.
The following insiders have purchased Rani Therapeutics Holdings, Inc. shares in the last 12 months: Imran Talat ($19,974), McKinley Kate ($29,993),